Thursday, April 7, 2011

Whitepaper - Discovering the Value of KOL Identification and Mapping

The paper will cover topic such as, targeting the right KOLs for specific roles, determining true KOL influence, allocating MSLs and sales-forces efficiently, and achieving the full benefit of hidden KOL value.

Download Whitepaper

All PharmaVOICE whitepapers

Whitepaper - Conquering the Challenges of Cancer Trial Accrual

This white paper discusses the challenges of finding clinical trial patients for oncology studies.

Click here

All PharmaVOICE whitepapers

Whitepaper - Clinical Labeling: The Benefits of an Approved Phrase Library

This white paper discusses the benefits of an approved phrase library.

Click here

All PharmaVOICE whitepapers

Whitepaper - Unveiling the Potential of the CEE Market

This white paper discusses the growth of the Eastern European market.

Click here

All PharmaVOICE whitepapers

Whitepaper - No More Product Losers! Strategic Lessons Learned

This white paper explores how to build a successful product strategy by using an analytical framework to evaluate opportunities, solid clinical data, and a careful market assessment to maximize product opportunities and avoid strategic mishaps.

Click here

All PharmaVOICE whitepapers

Whitepaper - Cancer Treatment in China: Implications and Opportunities for Pharma in 2011 and Beyond

This white paper discusses the implications and opportunities for cancer treatment in China.

Click here

All PharmaVOICE whitepapers

Whitepaper - Patient-Centered Wellness: Promoting Savings, Accountability and Health

This white paper discusses promoting patient-centered wellness.

Click here

All PharmaVOICE whitepapers

Whitepaper - Maximizing the Success of Your CRO Partnerships

This white paper discusses how to maximize the success of your CRO partnerships.

Click here

All PharmaVOICE whitepapers

Podcast: Oncology Trials: A Novel Approach to Patient Accrual

In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.

Click here

All PharmaVOICE podcasts

Podcast: Streamlining Clinical Trials with an Approved Phrase Library for Labeling

In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.

Click here

All PharmaVOICE podcasts

Podcast: Why ISMPP?: Leadership, Value, and Best Practices for Medical Publication Professionals

In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.

Click here

All PharmaVOICE podcasts

Podcast: Building a Communications Bridge: A Best Practice for Conducting Clinical Trials in India

In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.

Click here

All PharmaVOICE podcasts

Friday, February 25, 2011

Whitepaper - Increasing Planning Efficiency in Clinical Development

Explore trends and best practices for increasing planning efficiency in clinical development.

Click here

All PharmaVOICE whitepapers

Whitepaper - 3 Critical Elements of CRM in Rare Disorder Marketing

This whitepaper discusses the critical elements of CRM in rare disorder marketing.

Click here

All Pharmavoice whitepapers

Podcast: A New Wellness-Centric Ecosystem

In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.

Click here

All PharmaVOICE podcasts

Podcast: Best Practices for Your CRO Partnerships

In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.

Click here for podcast

Click here for related whitepaper

All PharmaVOICE podcasts

Podcast: Redefining CRM

In this episode, Katie Mihelich and Danielle Jamil provide a redefinition of CRM, and focus in on how it can be used in the rare disorder market space. They'll provide some best practices and key learnings about communicating with the stakeholders in the rare disorder community.

Click here for podcast

Click here for related whitepaper

All PharmaVOICE podcasts

Podcast: How Integrated Solutions Can Optimize Clinical Research

In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline which sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.

Click here

All PharmaVOICE podcasts

Podcast: Unveiling the Potential of the CEE Market

In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.

Click here

All PharmaVOICE podcasts